1. South Korea Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Amicogen, Inc.

Amicogen, Inc.

092040.KQ
Amicogen, Inc.KR flagKOSDAQ
1,246.00
KRW
+33.00
- -
70.92BMarket Cap

Total Valuation

Amicogen, Inc. carries a market capitalization of 70.92B, placing it among publicly traded companies globally. Its enterprise value stands at 148.54B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap70.92B
Enterprise Value148.54B

Share Statistics

Amicogen, Inc. currently has 70.45M shares outstanding.

Shares Outstanding70.45M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 2.14, and the price-to-book ratio stands at -5.70.

PE RatioN/A
PS Ratio2.14
PB Ratio-5.70
P/TBV Ratio0.73
P/FCF Ratio-2.03
P/OCF Ratio-1.96

Enterprise Valuation

EV / Sales3.42
EV / EBITDAN/A
EV / EBITN/A
EV / FCF0.03

Financial Position

Amicogen, Inc. maintains a current ratio of 1.07, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 46.70, indicating elevated leverage, while an interest coverage ratio of -2.06 demonstrates limited ability to service its debt obligations.

Current Ratio1.07
Quick Ratio0.19
Debt / Equity46.70
Debt / EBITDA-3.90
Interest Coverage-2.06

Financial Efficiency

Return on Equity (ROE)-550.26
Return on Assets (ROA)-1.86
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)8.23
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.61

Taxes

Over the trailing twelve months, Amicogen, Inc. has paid 1.24B in income taxes, reflecting an effective tax rate of 0.15.

Income Tax1.24B
Effective Tax Rate0.15

Stock Price Statistics

Amicogen, Inc.'s stock has declined approximately -66.23306% over the past 52 weeks. The 50-day moving average sits at 1,597.88, while the 200-day moving average is 2,158.11.

Beta (5Y)N/A
52-Week Price Change-66.23306%
50-Day Moving Average1,597.88
200-Day Moving Average2,158.11
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Amicogen, Inc. generated 43.44B in revenue and converted that into -4.54B in net income, yielding earnings per share of -90.30. EBITDA reached -15.95B, while operating income came in at -15.95B.

Revenue43.44B
Gross Profit6.64B
Operating Income-15.95B
Pretax Income-3.96B
Net Income-4.54B
EBITDA-15.95B
EBIT-15.95B
Earnings Per Share (EPS)-90.30

Balance Sheet

Amicogen, Inc. holds 7.81B in cash and equivalents against 62.28B in total debt, resulting in a net debt position of 54.69B. Total book value stands at -16.34B, with working capital of 2.88B providing operational flexibility.

Cash & Cash Equivalents7.81B
Total Debt62.28B
Net Debt54.69B
Equity (Book Value)-16.34B
Book Value Per Share-285.15
Working Capital2.88B

Cash Flow

Amicogen, Inc. produced -47.59B in operating cash flow over the past twelve months. After subtracting -1.39B in capital expenditures, free cash flow totaled -48.98B - equivalent to -854.80 per share.

Operating Cash Flow-47.59B
Capital Expenditures-1.39B
Free Cash Flow-48.98B
FCF Per Share-854.80

Margins

Amicogen, Inc. operates with a gross margin of 15.27, reflecting its pricing power and cost economics. The operating margin of -36.72 and net profit margin of -10.45 provide insight into operational efficiency.

Gross Margin15.27
Operating Margin-36.72
Pretax Margin-9.12
Profit Margin-10.45
EBITDA Margin-36.72

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield2.03
FCF Yield-49.38

Stock Splits

Amicogen, Inc.'s most recent stock split took place on December 13, 2023 with a 1:2 split ratio.

Last Split Date12/13/2023
Split Ratio1:2

Scores

Amicogen, Inc. posts an Altman Z-Score of 0.32, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score0.32